The CDC panel voted 14-0 with one recusal on Wednesday in favor of expanding use of the shot, days after the FDA authorized its use in the same age group.
The CDC panel voted 14-0 with one recusal on Wednesday in favor of expanding use of the shot, days after the FDA authorized its use in the same age group.
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться